Humana Inc vs Yum! Brands, Inc. — how do they compare? Humana Inc trades at $442 (market cap $47.61B), while Yum! Brands, Inc. trades at $143 (market cap $38.30B). The key difference: Humana Inc is the larger of the two by market cap, and Yum! Brands, Inc. pays the higher dividend (2.14%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Yum! Brands, Inc. for 132 Days on average.
| HUM | YUM | |
|---|---|---|
Market Cap | $47.61B | $38.30B |
Volume | 1,827,332 | 2,335,922 |
Sector | Health | Consumer Cyclical |
52-Week High | $409.85 | $168.16 |
52-Week Low | $163.67 | $135.77 |
Typical Hold Time | 53 Days | 132 Days |
Enterprise Value | $54.97B | $49.90B |
Dividend Yield | 0.89% | 2.14% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
YUM Brands trades at $143.00, up 2.26% with a bullish technical signal despite mixed moving averages. The company shows strong fundamentals with $8.21B revenue, 25.4% net margin, and consistent earnings beats. Recent developments include the Pizza Hut sale completion and KFC's new Open House concept testing. Cash flow remains positive with $115M net inflow in 2025, though high debt levels at $11.25B warrant monitoring.
YUM presents a compelling opportunity with analyst consensus target of $170.44 (19% upside) and 39% buy ratings. Strong franchise model and dividend growth (9 consecutive years) support investment case, but elevated debt and consumer spending sensitivity pose risks. The stock offers value at 17.68 P/E with potential from brand innovation and market expansion.
Trailing returns across standard periods
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →